Fresenius Medical Care AG - SPONSORED ADR (FMS)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q1 2024
32.2 M
Holdings value Q1 2024
$621 M
Value change Q1 2024
-$1.21 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
157
Number of buys Q1 2024
81
Number of sells Q1 2024
-59
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
358029106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 32.2 M $621 M -$1.21 M $19.28 157
2023 Q4 32.1 M $669 M +$510 K $20.83 152
2023 Q3 32 M $688 M -$25.4 M $21.54 139
2023 Q2 34.1 M $816 M -$114 M $23.93 137
2023 Q1 38.9 M $828 M -$107 M $21.26 143
2022 Q4 44.1 M $721 M +$191 M $16.34 145
2022 Q3 32.5 M $457 M -$40.2 M $14.04 129
2022 Q2 32.2 M $803 M +$53.2 M $24.94 149
2022 Q1 30.6 M $1.03 B +$97.8 M $33.68 169
2021 Q4 27.7 M $899 M +$54.2 M $32.46 166
2021 Q3 25.9 M $905 M +$191 M $34.97 150
2021 Q2 20.4 M $846 M +$44.5 M $41.57 168
2021 Q1 19.3 M $714 M +$311 M $36.88 162
2020 Q4 10.4 M $434 M +$61.9 M $41.56 161
2020 Q3 9.05 M $384 M +$321 K $42.48 170
2020 Q2 9.27 M $401 M +$18 M $43.28 165
2020 Q1 8.87 M $291 M -$31.8 M $32.80 151
2019 Q4 7.71 M $284 M +$32.1 M $36.83 150
2019 Q3 8.21 M $276 M -$7.93 M $33.59 144
2019 Q2 8.84 M $347 M -$264 K $39.28 152
2019 Q1 8.83 M $358 M -$93.9 M $40.53 167
2018 Q4 11.2 M $362 M -$140 M $32.39 169
2018 Q3 14.6 M $753 M -$4.11 M $51.42 205
2018 Q2 15.1 M $760 M -$7.64 M $50.35 210
2018 Q1 15.3 M $780 M +$23.8 M $51.08 219
2017 Q4 14.7 M $773 M -$202 M $52.55 209
2017 Q3 18.6 M $911 M +$126 M $48.89 201
2017 Q2 15.4 M $742 M -$31.3 M $48.33 181
2017 Q1 16.5 M $696 M +$30.9 M $42.13 179
2016 Q4 15.7 M $664 M +$4.83 M $42.21 178
2016 Q3 15.4 M $676 M +$53.8 M $43.77 173
2016 Q2 13.9 M $608 M +$22 M $43.57 164
2016 Q1 13.8 M $607 M +$162 M $44.08 163
2015 Q4 10 M $419 M -$44.4 M $41.84 142
2015 Q3 11.2 M $437 M +$1.74 M $39.01 131
2015 Q2 10.9 M $455 M -$11.9 M $41.59 137
2015 Q1 11.8 M $488 M -$13 M $41.45 135
2014 Q4 12.2 M $453 M -$28.4 M $37.14 135
2014 Q3 12.9 M $448 M -$19.2 M $34.70 123
2014 Q2 13.5 M $452 M -$28.8 M $33.49 129
2014 Q1 14.3 M $500 M -$53.9 M $34.85 124